Mat De Costa
About Mat De Costa
Mat De Costa serves as the ALS Key Account Manager at Amylyx Pharmaceuticals, where he has successfully increased the community utilization of Relyvrio from zero to six prescribers in 2023. With a strong background in pharmaceuticals and a Master's degree in Business Administration, he has built relationships with ALS specialists and actively participates in community advocacy efforts.
Work at Amylyx Pharmaceuticals
Mat De Costa serves as the ALS Key Account Manager at Amylyx Pharmaceuticals, a position he has held since 2023. In this role, he focuses on increasing the utilization of Relyvrio, a treatment for ALS. He successfully expanded the prescriber base from zero to six prescribers within the first year. De Costa has also played a significant role in enhancing patient education to decrease the discontinuation rate of Relyvrio. His efforts include collaborating with care coordinators and the Reimbursement team to ensure financial accessibility for ALS patients.
Education and Expertise
Mat De Costa holds a Bachelor of Science degree in Marketing with a minor in Finance from Providence College, where he studied from 1998 to 2002. He furthered his education by obtaining a Master's degree in Business Administration from the University of Rhode Island, completing his studies from 2004 to 2008. His educational background has equipped him with a strong foundation in marketing and finance, which he applies in his current role in the pharmaceutical industry.
Professional Background
De Costa has a diverse professional background in the pharmaceutical and healthcare industries. Prior to his current role, he worked at Alexion Pharmaceuticals as a Neuromuscular Regional Account Manager from 2021 to 2023. His experience also includes positions at Otsuka Pharmaceutical Companies as a Hospital Account Manager, Nephrology Rare Disease, and at Olympus Corporation of the Americas as an EndoTherapy Territory Manager. Earlier in his career, he held roles at Novartis Pharmaceuticals, Quest Diagnostics, and Hasbro.
Achievements in Sales and Community Engagement
In 2024, Mat De Costa achieved 122% sales attainment year-to-date in his role at Amylyx Pharmaceuticals. He has effectively increased the prescriber base for Relyvrio from 8 to 15 providers within the first eight months of his tenure. De Costa actively participates in community events, including ALS walks and advocacy meetings, to support ALS awareness and patient advocacy. His efforts have contributed to building strong professional relationships with ALS specialists at prominent institutions such as Yale, UMass, and Rhode Island Hospital.